Misonix Announces New Distribution Agreement for Belgium and Luxembourg

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year, exclusive distribution agreement with Sophysa Benelux, based in Braine l’Alleud, Belgium, for the distribution of the SonaStar™ Ultrasonic Surgical Aspirator and the BoneScalpel™ Ultrasonic Bone Cutter.

The agreement provides Sophysa with the rights to sell in Belgium and Luxembourg, and includes minimum purchase requirements.

Sophysa is acknowledged as a market leader and has built a reputation as a distributor of state-of-the-art medical devices and capital equipment, with special emphasis in neuro and spine surgery.

The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt™ bone shaving technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.

The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures. It offers the convenience and speed of a power instrument without the potential hazards associated with rotary sharps.

“Misonix welcomes Sophysa Benelux to our growing sales and distribution organization. We know Sophysa as a first tier distributor of advanced medical equipment in the Benelux countries,” said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. “Sophysa has established themselves as a quality distribution partner for successfully introducing high tech medical devices to their markets. We are particularly pleased that they will be distributing two of our product platforms through their well established channels.”

Source:   Misonix

Share your thoughts

Your email address will not be published.